Clinical trial
Comparison of Outcome and Effectiveness Between Micropulse Diode Laser Cyclophotocoagulation and Cyclocryoablation in Treatment of Refractory Glaucoma
NCT05437614 is registered in ClinicalTrials.gov with University of Health Sciences Lahore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Outcome and Effectiveness Between Micropulse Diode Laser Cyclophotocoagulation and Cyclocryoablation in Treatment of Refractory Glaucoma
- Lead sponsor
- University of Health Sciences Lahore
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 1, 2022
- Completion date
- March 1, 2023
- Enrollment
- 47 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
treatment of refractory glaucoma